Phase 3 trial of Rybrevant plus chemotherapy in lung cancer meets primary endpoint: Janssen Ruchika Sharma18 July 2023 1:30 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the Phase 3 PAPILLON study ...
Cardiorespiratory fitness prevents risk and death due to colon, lung and prostate cancer in MEN Aditi5 July 2023 8:00 PM ISTAn Original Investigation on Nutrition, Obesity, and Exercise published on June 29, 2023, in JAMA Network Open by lead author Dr Elin and colleagues...
Nivolumab plus chemotherapy improves survival in Stage III Non-Small-Cell Lung Cancer: NEJM Chumbeni30 Jun 2023 8:00 PM ISTSpain: A recent study published in The New England Journal of Medicine has revealed that combining Nivolumab and Chemotherapy treatment in patients...
Medical Bulletin 9/June/2023 Isra Zaman9 Jun 2023 4:45 PM ISTHere are the top medical news for the day:Its Possible to reverse devastating heart condition for the 1st timeThree men who had heart failure caused...
Long Covid impact on fatigue and quality of life worse than some cancers Isra Zaman9 Jun 2023 9:15 AM ISTFatigue is the symptom that most significantly impacts the daily lives of long Covid patients, and can affect quality of life more than some cancers,...
Lung cancer pill drastically cuts risk of death after surgery Roshni Dhar7 Jun 2023 5:43 PM ISTA once-daily pill halved people’s risk of dying from a common lung cancer when they took the drug after tumour-removal surgery, trial results from a...
Health Bulletin 6/June/2023 Roshni Dhar6 Jun 2023 5:10 PM ISTHere are the top health stories for the day:Deadly heart attacks 13 more likely on a monday: StudySerious heart attacks are more likely to happen at...
Bristol Myers Squibb gets USFDA priority review for lung cancer treatment Repotrectinib Ruchika Sharma1 Jun 2023 2:00 PM ISTNon-small cell lung cancer is one of the most common types of lung cancer, representing up to 84% of diagnoses.
Bristol Myers Squibb receives EMA panel recommendation for approval of Opdivo with chemotherapy for lung cancer patients Ruchika Sharma29 May 2023 11:30 AM ISTOpdivo is a programmed death-1 immune checkpoint inhibitor that is designed to uniquely harness the body's own immune system to help restore...
Medical Bulletin 27/May/2023 Isra Zaman27 May 2023 4:30 PM ISTHere are the top medical news for the day:Eating natto might help to distressHealth is wealth as the saying goes and new research now shows that it is...
Plants eliminate cancer causing toxins from air Isra Zaman27 May 2023 9:00 AM ISTA ground-breaking study has revealed that plants can efficiently remove toxic gasoline fumes, including cancer causing compounds such as benzene, from...
Cemiplimab plus chemotherapy prolongs life and improves QoL in patients with advanced lung cancer Dr. Kamal Kant Kohli16 May 2023 11:00 AM ISTUSA: Cemiplimab plus chemotherapy can improve survival and also affects quality of life in patients with advanced lung cancer versus placebo...
